Immunohistochemical studies of prostate carcinoma reveal that most pri
mary carcinomas, including high-grade tumors, are surrounded by a basa
l lamina composed of laminin, type IV collagen, and entactin. In addit
ion to the expected laminin subchains A, B-1, B-2, subchains M and S a
re also found. Tenascin, found around normal glands, is seen in 60%, o
f carcinomas. The basal cells of the normal gland express several inte
grin cr units including alpha(2,3,4,5,6,) and v. Both beta(1) and beta
(4) subunits are observed. These integrin units are polarized at the b
ase of the cells where they codistribute with the surrounding extracel
lular matrix. The integrin alpha(6) beta(4) is associated with hemides
mosomal-Like structures, as detected by transmission electron microsco
py (TEM). In carcinoma, the beta(4) is not observed and the alpha(6) a
nd beta(1) subunits are variably expressed. The integrin expression in
carcinoma is diffuse in the cytoplasmic membrane and not restricted t
o the basal aspects of the cell. In addition, type VII collagen and th
e BP 180 protein which are associated with hemidesmosomes are lost, al
though the BP 230, plectin, and HD1 proteins are variably expressed. U
sing immunohistochemistry and northern analysis we obser ed three meta
lloproteinases in prostate carcinoma-matrilysin, gelatinase A, and gel
atinase B. Western blotting and zymogram analysis reveal that of these
three, only matrilysin appears to be present in its active form. Rece
nt in situ hybridization studies reveal focal expression of the matril
ysin mRNA in 25/33 primary carcinomas. Matrilysin also appears to be h
ighly expressed in prostatic ducts and atrophic glands. Expression of
the three metalloproteinases is also seen in prostatic intraepithelial
neoplasia lesions. The lysosomal protease cathepsin D is focally expr
essed in 39/78 carcinomas. This expression shows a tendency to increas
e with histologic grade (p = 0.055), and is related to pathologic stag
e (p = 0.031). These proteases most likely participate in a cascade of
enzymatic reactions which include the plasminogen activator, urokinas
e. During prostate tumor progression, alterations occur in the extrace
llular matrix, cellular surface integrins, and protease expression, su
ggesting a dynamic remodeling of tissue. Further analysis of these alt
erations are ongoing in an effort to determine the value of these fact
ors as prognostic indicators of the disease. (C) 1994 Wiley-Liss, Inc.